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Abstract
Background: The individual contribution of genes in the HLA region to the risk of developing type 1 diabetes (T1D) is
confounded by the high linkage disequilibrium (LD) in this region. Using a novel approach we have combined genetic
association data with information on functional protein-protein interactions to elucidate risk independent of LD and to
place the genetic association into a functional context.
Methodology/Principal Findings: Genetic association data from 2300 single nucleotide polymorphisms (SNPs) in the HLA
region was analysed in 2200 T1D family trios divided into six risk groups based on HLA-DRB1 genotypes. The best SNP signal
in each gene was mapped to proteins in a human protein interaction network and their significance of clustering in
functional network modules was evaluated. The significant network modules identified through this approach differed
between the six HLA risk groups, which could be divided into two groups based on carrying the DRB1*0301 or the
DRB1*0401 allele. Proteins identified in networks specific for DRB1*0301 carriers were involved in stress response and
inflammation whereas in DRB1*0401 carriers the proteins were involved in antigen processing and presentation.
Conclusions/Significance: In this study we were able to hypothesise functional differences between individuals with T1D
carrying specific DRB1 alleles. The results point at candidate proteins involved in distinct cellular processes that could not
only help the understanding of the pathogenesis of T1D, but also the distinction between individuals at different genetic
risk for developing T1D.
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Introduction
Type 1 diabetes (T1D) is a disease of complex aetiology believed
to be influenced by multiple genetic and environmental risk
factors. The major genetic signal for T1D is located in the human
leukocyte antigen (HLA) region on the short arm of chromosome 6
(6p21.3). The contribution of this region to the risk of developing
T1D has been known for over thirty years [1], however the
causative variant or variants have yet not been fully identified. The
major susceptibility for T1D has been mapped to the HLA class II
genes HLA-DQB1, -DQA1 and -DRB1 [2,3]. Both susceptible and
protective DR-DQ haplotypes exist in all populations [4].
Associations from other genes in the region have also been
reported [5–11], however the extremely high linkage disequilib-
rium (LD) covering a large part of the HLA region makes it
difficult to detect independent effects of individual genes [3] and
these studies may have suffered from lack of statistical power to
identify true effects due to small sample sizes and not dense
enough genotyping. Recently novel statistical methods have been
applied to genetic association data from the HLA region in T1D,
and this has made it possible to identify effects of other genes
independently of the effects at the classical HLA-DR, -DQ risk loci.
These include HLA-B and HLA-A, located telomeric of the classical
loci, and loci within the HLA class III region [12–16]. Still these
new loci together with the HLA-DQB1, -DQA1 and -DRB1 loci
cannot explain the full effect of this region. Additional loci with
smaller or rarer effects are likely to exist. To detect such variants,
we have focused on the development of an approach that
investigates functional protein-protein interactions encoded by
genes within the HLA region.
Functional relationships (e.g. co-expression, structural similarity,
physical interactions) between proteins have been used to infer
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phenotypic effects of mutations in their corresponding genes. A
thorough benchmark of the predictive power of different types of
relationships showed that proteins involved in the same protein
complexes had the highest tendency to also cause the same
phenotype when mutated [17]. Thus, proteins interacting
physically tend to be involved in similar phenotypes, which has
been shown in several species [18–21]. With several large-scale
protein-protein interaction screens across different organisms
being available, protein-protein interactions can now be applied
systematically to discover new disease genes [22,23].
In this study we have used an approach that combines genetic
association data with information on protein-protein interactions
to identify additional genes within the HLA region that contribute
to the pathogenesis of T1D. Information on protein interactions
for genes that contribute to susceptibility of complex diseases may
give valuable clues of not only the functional implication of
candidate genes but also about additional candidates. The genetic
data was generated by the Type 1 Diabetes Genetics Consortium
(T1DGC), in an effort to fine map the HLA region in a large
cohort of T1D families collected world-wide, but mostly of
Caucasian ethnicity. We have previously validated the method in a
study of a subset of the T1DGC families in order to test whether
information on functional interaction pathway could help explain
the effects of the HLA region on the risk of developing T1D [24].
Here we expand the study to contain over 2200 affected offspring
trios and test whether different HLA-DRB1 genotypes carried by
the diabetic offspring could confer different risk due to underlying
differences at a functional level.
Methods
Ethics Statement
All study participants, their parents or guardians gave written
consent to participate and the study protocol was approved by
relevant Ethics Committees and Institutional Review Boards in
each country contributing family material to the study (Danish:
Den Videnskabsetiske Komite´ for Københavns Amt # KA
04090g).
Figure 1. Overview of the developed approach. A) Genes located in the HLA region were identified and B) mapped to nodes or proteins in a
2nd order network in the InWeb. C) HLA proteins and their interaction partners were used as bait to produce virtual pull-downs of network modules.
D) Identified network modules were reduced to only contain proteins from the HLA region, as these could be associated to signals from the TDT
analysis. E) SNPs from the TDT analysis were mapped to genes + 2000 bp up- and downstream the transcription start and stop site respectively. The
best SNP signal for each gene was then mapped to the corresponding proteins in the network modules.
doi:10.1371/journal.pone.0009576.g001
T1D - HLA Protein Interactome
PLoS ONE | www.plosone.org 2 March 2010 | Volume 5 | Issue 3 | e9576
Samples
The dataset generated by the T1DGC comprised 2321 T1D
affected sib-pair families (release 2007.02.MHC). The samples
comprised families from nine cohorts, Asia Pacific (AP), British
Diabetes Association (BDA), Denmark (DEN), Europe (EUR),
Human Biological Data Interchange (HBDI), Joslin (JOS), North
America (NA), Sardinia (SAR) and United Kingdom (UK). All
diabetic individuals were diagnosed before 35 years of age with
continued insulin treatment since diagnosis.
Genotyping
Genotyping was performed on two chip arrays (OPA1 and
OPA2) of 1536 SNPs each from the Illumina Golden Gate
technology (San Diego, CA, USA). 115 SNPs were in common on
the two chips resulting in 2957 unique SNPs distributed
throughout the 4 Mb classical HLA region. In addition to the
SNP genotyping all individuals were also genotyped for alleles in
classical HLA genes (HLA-A, HLA-B, HLA-Cw, HLA-DPA1, HLA-
DPB1, HLA-DQA1, HLA-DQB1 and HLA-DRB1) using PCR-based
Figure 2. P-value distribution for HLA specific networks and the reference group. A) DR3/DR3: most extreme deviation higher D= 0.2083,
p,0.001. B) DR3/DRX: most extreme deviation higher D= 0.3347, p,0.001. C) DR3/DR4: most extreme deviation lower D= 0.2890, p,0.001. D) DR4/
DR4: most extreme deviation lower D= 0.4772, p,0.001. E) DR4/DRX: most extreme deviation lower D=0.1586, p,0.001. F) DRX/DRX: most extreme
deviation lower D= 0.3199, p,0.001. Dashed line: HLA risk group, solid line: reference group.
doi:10.1371/journal.pone.0009576.g002
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sequence-specific oligonucleotide probes and line strips from
Roche Molecular Systems (Pleasanton, CA, USA). The genotyp-
ing was presented at a four-digit level except for the BDA cohort.
For details on DNA samples, genotyping and QC provided by the
T1DGC see [25].
HLA-DRB1 Stratification
We used the information on HLA-DRB1 genotypes to stratify
the probands according to carriage of the *0301, *0401 or non-
*0301/non-*0401 alleles (here called X). For the probands that
did not have four-digit genotyping their two-digit genotype 03 or
04 was used for stratification. This divided the probands and their
two parents into six different genotype groups: DR*0301/
DR*0401 (DR3/DR4), DR*0401/DR*0401 (DR4/DR4),
DR*0301/DR*0301 (DR3/DR3), DR*0401/DRX (DR4/DRX),
DR*0301/DRX (DR3/DRX) and DRX/DRX ranked according to
their conferred risk of T1D.
Statistical Analyses
Individuals were removed for low genotyping success rate
(,90%). SNPs were removed for low genotyping success rate
(,95%), a minor allele frequency less than 1%, deviation from
Hardy Weinberg equilibrium (p,0.001) in controls, and if
Mendelian errors were detected. Individuals that were removed
for low genotyping reduced the number of full affected offspring
trios available for analysis to 2214. They were analysed for
association for the remaining SNPs using the transmission
disequilibrium test (TDT) [26]. All genetic analyses were
performed using the program PLINK [27]. The six datasets
were analysed separately for association by TDT using the quality
criteria mentioned. This resulted in 589 trios being analysed for
2317 SNPs in the DR3/DR4 group (26.6%), 145 trios for
2295 SNPs in DR4/DR4 (6.5%), 202 trios for 2289 SNPs in
DR3/DR3 (9.1%), 444 trios for 2369 SNPS in DR4/DRX
(20.1%), 570 trios for 2358 SNPs in DR3/DRX (25.8%) and 264
trios for 2389 SNPs in the DRX/DRX group (11.9%). More than
97% of the probands in the highest risk group, DR3/DR4, carried
the high risk DQB1*0302 allele associated with the DR4-DQ8
haplotype.
Protein-Protein Interaction Networks
Protein interaction experiments are plagued by high numbers of
false positive interactions and often low coverage. In order to
derive a high-quality human interactome (the Inweb), we 1)
combined several large scale protein-protein interaction databases,
2) inferred protein-protein interactions from model organisms, and
3) defined a quality control score for each interaction. For the
purpose, we integrated interactions in 23,296 peer-reviewed
articles retrieved from large protein-protein interaction databases
and using the InParanoid orthology database, we inferred human
protein-protein interactions from experiments in model organisms
[22]. All interactions were scored and benchmarked against a gold
standard to ensure that only high-confidence interactions were
used in the analysis. The resulting interactome contained 313,524
unique scored protein-protein interactions covering 12,275
proteins.
Table 1. The top significant networks modules identified for each HLA risk group.
HLA risk group Baita) Chromosome
Whole pull down
(#Proteins)
HLA proteins
(#Proteins) P-valueb)
Reference p-
valuec)
Adjusted p-
valued)
DR3/DR3 RCN2 15q23 66 5 0,0018 0,0545 0,0330
TRAF6 11p12 258 6 0,0026 0,0615 0,0423
Q5SP16 6p21 389 9 0,0041 0,0667 N.S
ACTA1 1q42 117 5 0,0071 0,0848 N.S
TNFRSF1A 12p13 161 8 0,0077 0,0855 N.S
DR3/DRX HSPA1A 6p21 389 9 0,0057 0,0545 N.S
CSE1L 20q13 466 7 0,0061 0,0615 N.S
CAD 2p21 979 14 0,0098 0,0667 N.S
TRAF6 11p12 258 6 0,0113 0,0848 N.S
RCN2 15q23 66 5 0,0145 0,0855 N.S
DR3/DR4 HCRT 17q21 3 2 0,0024 0,0545 0.0440
PSMB8 6p21 30 4 0,0085 0,0615 N.S
CD4 12p13 100 6 0,0096 0,0667 N.S
PSMB9 6p21 31 3 0,0302 0,0848 N.S
TAP1 6p21 22 5 0,0318 0,0855 N.S
DR4/DR4 HCRT 17q21 3 2 0,012 0,0545 N.S
CD4 12pter 100 6 0,0406 0,0615 N.S
DR4/DRX HCRT 17q21 3 2 0,0242 0,0545 N.S
HLA-DRA 6p21 9 3 0,0289 0,0615 N.S
DRX/DRX HLA-DRA 6p21 9 3 0,0385 0,0545 N.S
a)Bait specifies the protein that was used to capture each network.
b)The p-value after permutation for each HLA risk group.
c)The p-value without HLA risk group stratification as a reference.
d)The p-value for each protein network after correction with the reference.
doi:10.1371/journal.pone.0009576.t001
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Discovering Protein-Protein Interaction Networks
Involved in Diabetes
1) The resource. As the genetic analyses specifically focused on
the HLA region, we derived a protein interaction network of
all proteins translated from genes in this region and their
respective interaction partners. Such a network is often
referred to as a 2nd order protein-protein interaction
networks and here we will refer to the resource as the
HLA-relevant protein-protein interaction network.
2) Generating protein-protein interaction modules. Each gene
in the HLA-relevant protein-protein interaction network
was used as bait protein in a virtual pull-down, i.e. a module
consisted of a bait protein and its direct protein-protein
interaction partners. This approach resulted in an inventory
of modules that could be screened for association to T1D.
3) Genetic association and proteins. The TDT p-value for the
SNP with the highest association to T1D was assigned to
each gene including 2000 bp up- and downstream the
transcription start and stop site, respectively. Thus each
protein was associated to the most significant SNP lying
within the gene.
4) Cleaning up modules. As the association data from the HLA
region only covers ,6% of the nodes in the HLA-relevant
protein-protein interaction network, each module was
reduced to only include genes with associated TDT p-
values. Hereby, modules in the inventory only included gene
products from the HLA region. Pull-downs with less than
two associated genes were dropped.
5) Clustering of genetic association. For each protein-protein
interaction module, the TDT p-values associated with each of
the proteins were combined using a simple average. The
combined TDT p-value for that module was then compared
to a distribution of TDT p-values generated from 10,000
randomly sampled modules of the same size, i.e. the final p-
value of a module was calculated as by dividing the number of
randommodules with a better combined p-value with 10,000.
The steps 3) to 5) were repeated for each experiment for all six
HLA genotype risk groups. The most significantly enriched
modules were selected for thorough study. Figure 1 gives an
overview of the developed approach.
In order to test whether the genetic association clustered within
the HLA risk groups, we clustered the genetic association across all
HLA groups as a reference. A two-sample Kolmogorov-Smirnov
test was used to compare the p-value distributions for each of the
HLA risk groups with the reference distribution (Figure 2).
Table 1 lists the most significant network modules in each HLA
risk group with information on bait proteins, the number of
interaction partners within and outside the HLA region and p-
values before and after correction with the reference.
Construction of Consensus Networks
Many proteins identified in the networks were present in more
than one network and the number of interaction partners for these
proteins was often large. To reduce the redundancy and identify
interaction partners of special interest we used the information
from all significant network modules within risk groups to
construct consensus networks. For each HLA risk group, the
number of times a gene was present at baseline in significant
modules was counted. Table 2 summarises the most frequent
genes within each group. As the number of baseline significant
networks varies between the HLA risk groups, all genes appearing
more than half as many times in baseline significant modules as the
most frequent gene were used to seed a consensus HLA risk group-
specific network associated with T1D. The consensus networks
were visualised using Cytoscape [28].
Results
205 genes from the HLA region could be mapped to nodes (or
proteins) in the Inweb protein interaction network. In total, 744
pull-downs were constructed containing genes within the HLA
region. Network modules significantly enriched for proteins from
the HLA region were identified for each of the six HLA risk groups
separately after the randomisation. The highest number of
significant modules (p,0.05) was found for the DR3/DR3 and
the DR3/DRX group, with 44 and 26 modules respectively.
Looking closer at these results we found that 16 of the modules
were shared between the DR3/DR3 and DR3/DRX groups.
Similarly, the groups DR3/DR4, DR4/DR4 and DR4/DRX also
showed an overlap of significant network modules. These three
groups however, contained substantially fewer significant modules
compared to the groups that did not carry a DRB1*0401 allele (6,
2 and 2 modules respectively). One module was found significant
in the low risk DRX/DRX group. Figure 2 plots the distribution
of p-values for the network modules for each of the six HLA risk
groups compared to all HLA groups combined as reference. For
each of the six HLA risk groups, we found more enrichment
Table 2. Summarization of the genes occurring most
frequently in the network modules for each HLA risk group.
HLA risk group Gene Chromosome
Times occurring
in networks
DR3/DR3 HSPA1A 6p21 42
HSPA1B 6p21 42
HSPA1L 6p21 28
TUBB 6p21 23
C6orf48 6p21 17
LY6G5B 6p21 14
DDR1 6p21 11
DR3/DRX HSPA1A 6p21 21
HSPA1B 6p21 21
TUBB 6p21 16
LY6G5B 6p21 15
HSPA1L 6p21 14
DR3/DR4 TAP2 6p21 3
PSMB8 6p21 3
HLA-DQA1 6p21 3
TAP1 6p21 3
PSMB9 6p21 2
HLA-DQB1 6p21 2
DR4/DR4 HLA-DQA1 6p21 2
HLA-DQB1 6p21 2
DR4/DRX and DRX/DRX HLA-DRB1 6p21 1
HLA-DRB5 6p21 1
HBB 11p15.5 1
HLA-DMA 6p21 1
HLA-DRA 6p21 1
doi:10.1371/journal.pone.0009576.t002
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Table 3. Genes in consensus network of the DR3/DR3 and DR3/DRX groups.
DR3/DR3
DR3/DRX
Gene Full name Chromosome GO terms Description
HSPA1A Heat shock 70 kDa
protein A1
6p21.3 1) anti-apoptosis 2) mRNA catabolic
process 3) response to unfolded protein
4) unfolded protein binding
Candidate gene in T1DM linked to the DR3 haplotype [37,38]. Not
replicated in a Japanese and American study [39,40]. Up-regulated
by cytokines in b-cells and primary islets [41,42]. Increased T-cell
response to and high levels of autoantibodies against HSP70 was
detected in newly diagnosed children with T1D [43].
HSPA1L Heat shock 70 kDa
protein-like 1
6p21.3 1) response to unfolded protein Also called HSP70-HOM. The sequence is 90% identical to HSPA1A.
Polymorphisms have been associated with T1D [38].
C6ORF48 Chromosome 6 open
reading frame 48
6p21.3 - Differentially expressed in patients with symptomatic parvovirus B19
infection, which is coupled to high levels of circulating pro-
inflammatory cytokines, arthritis and chronic fatigue syndrome [44].
TUBB Tubulin beta 6p21.3 1) cell motion 2) natural killer cell
mediated cytotoxicity 3) MHC class I
protein binding
Tubulin alpha and beta are components of the microtubules with
very diverse functions of the cell structure. TUBB has been identified
as a key player involved in protein-interaction networks in T1D
[24,45].
CSNK2B Casein kinase 2
beta subunit
6p21.3 1) signal transduction 2) identical
protein binding 3) protein domain
specific binding 4) protein
serine/threonine kinase activity
Encodes a regulatory subunit controlling the activity of the CK2
protein. A constitutively active kinase, expressed in all human tissues
and implicated in a wide variety of cellular functions [46]. Mostly
studied in cancers and apoptosis where it was found to control
caspase-mediated degradation of pro-apoptotic members of the Bcl-
2 family [46]. Regulated by pro-inflammatory agents such as IL-1 and
LPS [47]. Phosphorylates and modulates action of several
transcription factors involved in inflammation, including NF-kB and
STAT1 [47].
DDR1 Discoidin domain
receptor tyrosine
kinase 1
6p21.3 1) cell adhesion 2) protein binding 3)
transmembrane receptor protein
tyrosine kinase activity
Encodes a nonintegrin collagen receptor constitutively expressed on
epithelial cells. Involved in differentiation of human monocytes into
macrophages via a MAPK pathway [48]. Collagen-activation in cells
over-expressing the DDR1b isoform lead to up-regulated expression
and release of several cytokines and chemokines such as IL-1b, IL-8,
MIP-1a and MCP-1. The up-regulation was dependent on NF-kB,
indicating a role for DDR1 in the development of an inflammatory
response [48].
SLC5A1 Solute carrier family
5 (sodium/glucose
cotransporter),
member 1
22q12.3 1) glucose transport 2) glucose:sodium
symporter activity 3) protein binding
Glucose down-regulated the pro-inflammatory response in intestinal
epithelial cells mediated by SLC5A1 activity, via a pathway leading to
an alteration of NF-kB nuclear translocation [49]. SLC5A1 expression
was, however, not altered by prolonged hyperglycaemia in coronary
artery epithelial cells in streptozytocin-treated rats [50].
MSR1 Macrophage
scavenger receptor 1
8p22 1) cholesterol transport 2) lipoprotein
particle clearance 3) positive regulation
of foam cell differentiation 4) receptor-
mediated endocytosis 5) low-density
lipoprotein binding 6) scavenger
receptor activity
Genetic variations in MSR1 was linked to hereditary forms of prostate
cancers [51,52] providing a link to inflammation. MSR1 was found to
regulate tolerance against apoptotic cells in a mouse model of SLE,
and SLE patients carried autoantibodies against MSR1 [53] indicating
a role in autoimmunity.
TSSK6 Testis-specific serine
kinase 6
19p13.11 1) protein amino acid phosphorylation
2) sperm chromatin condensation 3) ATP
binding 4) magnesium ion binding
5) protein serine/threonine kinase activity
Most abundant in human testis but has been detected in all human
tissues. Specifically phosphorylate histones H1, H2A, H2AX and H3
and form stable complexes with heat shock proteins (incl. HSP70)
during spermiogenesis [54].
OLR1 Oxidised low density
lipoprotein (lectin-like)
receptor 1
12p13-p12 1) blood circulation 2) proteolysis Oxidised-LDL up-regulates the expression of OLR1 on vascular
endothelial cells [55]. Up-take of ox-LDL is highly injurious for
epithelial cells and involved in atherosclerosis. Involved in antigen
cross-priming in dendritic cells, in which exogenous antigens are
processed via MHC class I pathway and initiate cytotoxic T-
lymphocyte response mediated via HSP70 [56]. Expressed on
macrophages where it may function as a scavenger receptor (see
MSR1) [57].
SAP30L Sin3A associated
protein-like
5q33.2 - Identified as a gene with expression up-regulated by TGF-b in T84
colon carcinoma cells but was found to be expressed in several
human tissues. Protein sequence is 70% identical to SAP30 [58].
Associated with the Sin3A-HDAC co-repressor complex regulating
gene expression by deacetylating histones [59]. HDAC inhibitors was
shown to block the production of inflammatory mediators, such as
NO and cytokines, in animal models of rheumatoid arthritis and SLE
[60,61]. In INS-1 cells, HDAC inhibitors were shown to prevent
cytokine-induced b-cell apoptosis and impaired b-cell function by
down-regulating NF-kB activity [62].
T1D - HLA Protein Interactome
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amongst the most significant clusters than we did when combining
the samples across all HLA groups. The Kolmogorov-Smirnov test
showed that the DR3/DR3 and the DR3/DRX groups were
significantly more clustered than the combined sample (p,0.001),
while the other four HLA risk groups generally were less clustered
than the reference, except for the most associated networks. Of 81
significant networks identified after the randomisations three
remained significant after adjusting the p-values with the
reference, giving an FDR of 0.96. After correction we assume
an FDR of 0.05 for the remaining three networks (Table 1).
Proteins in Identified Network Modules
For the DR3/DR3 and DR3/DRX risk groups proteins from
the HLA region that were identified in significant network
modules were found to overlap substantially. One protein in
particular, the heat shock 70 kDa protein A1 (HSPA1A), was found
in all of the most significant modules for these two groups. The two
proteins HLA-B-associated transcript 3 (BAT3) and c6orf48 were
also found together in three of the networks. Similarly, the
modules in common between the DR*0401 allele-carrying groups
(DR3/DR4, DR4/DR4 and DR4/DRX) were found to contain
proteins that occurred multiple times. These were represented by
classical HLA class II proteins, such as HLA-DQB1, -DQA1,
proteasome subunits 8 and 9 (PSMB8, PSMB9) and transporter 1,
ATP-binding cassette sub-family B (MDR/TAP) (TAP1) and
transporter 2, ATP-binding cassette sub-family B (MDR/TAP)
(TAP2). The single significant network module in the heteroge-
neous DRX/DRX group contained the classical HLA proteins
HLA-DRB1, -DRB5, -DMA and -DRA.
Consensus Networks
Consensus networks for the six different HLA groups were
constructed from the most abundant proteins in the significant
modules to create a second order network. Their interaction
partners outside the HLA region where included at the highest
stringency level to visualise informative interaction pathways in
which the HLA proteins are involved. The proteins and their
functional implications in relation to immunity and T1D
pathogenesis are summarised in Table 3 for the DRB1*0301
associated consensus network and Table 4 for the DRB1*0401
associated consensus networks.
The DR3/DR3 and the DR3/DRX groups shared the same
consensus network centred around six proteins from the HLA
region. The HLA proteins were identified as HSPA1A, HSPA1L
(old name HSP70-Hom), c6orf48, tubulin beta (TUBB), casein
kinase 2 beta subunit (CSNK2B) and discoidin domain receptor
tyrosine kinase 1 (DDR1). Figure 3A shows their interaction
relationships within and outside the HLA region and Table 3
summarises their information.
Two consensus networks were shared by the DR3/DR4 and
the DR4/DRX group. The smallest network containing the
protein hypocretin (HCRT) was also the consensus network for the
DR4/DR4 group. Once again they contained the proteins HLA-
DQB1, -DQA1, PSMB8, PSMB9, TAP1 and TAP2 and their
interaction partners outside the HLA (Figure 3B and C and
Table 4).
Discussion
The complex nature of the human HLA region on chromosome
6, with the extraordinarily high LD between genes, has made it
extremely difficult to elucidate the effect of individual genes for the
risk of developing T1D. A recent fine mapping study of the HLA
region in T1D has identified and replicated additional risk loci
within the HLA class I region [12]. Independent association
signals were identified for HLA-A and HLA-B, where HLA-B*039
conferred the highest risk for susceptibility. The class II-
independent association of HLA-A and HLA-B has been replicated
by recent studies [13–15]. Furthermore, evidence for independent
association has been reported for the HLA-DPB1 locus [13,15] and
for loci in the HLA class III region [16]. Other loci have failed to
replicate, such as the ITPR3 gene [10]. Most of these recent studies
have used data generated by the T1DGC, and they use refined
statistical methods to control for the complexity of the HLA region
due to the extended LD and highly polymorphic loci. Still the
divergence of some results indicates the difficulty of dissecting the
independent genetic contribution of genes in this region to the risk
of developing T1D. It is likely that more genes with individual but
smaller or rarer effects on diabetes risk can be identified in this
DR3/DR3
DR3/DRX
Gene Full name Chromosome GO terms Description
ZNF44 Zinc finger protein
44
19p13.2 1) protein binding Identified in a screening of a placental genomic library for His/Cys
motifs linking adjoining zinc fingers. Clones were then cross-
hybridised to known zinc-finger-encoding cDNAs from a human T-
cell cDNA library [63].
COL11A1 Collagen, type XI,
alpha 1
1p21 1) collagen fibril organization 2) detection
of mechanical stimulus involved in sensory
perception of sound 3) visual perception
4) extracellular matrix binding
5) extracellular matrix structural constituent
6) protein binding, bridging
Type V and XI collagens are minor fibril-forming collagens with
different tissue localisation but with closely related structural and
biological properties [64]. COL11A1 encodes the alpha 1 polypeptide
that forms the heterotrimeric type XI collagen together with alpha 2
(XI) and alpha I (II) polypeptides.
COL5A2 Collagen, type 5,
alpha 2
2q32 1) collagen fibril organization 2) eye
morphogenesis 3) skin development
COL5A2 encodes the alpha 2 polypeptide that forms the
heterotrimeric type V collagen together with the alpha 1 (V)
polypeptide and a second alpha 2 (V) polypeptide.
GO terms on biological process and molecular function from www.geneontology.org.
Abbreviations: IL, interleukin; LPS, lipopolysaccharide; NF-kB, nuclear factor-kappa beta; STAT1, signal transduction and activator of transcription 1; MAPK, mitogen-
activated protein kinase; MIP-1a, macrophage inflammatory protein-1a; MCP-1, monocyte chemoattractant protein-1; SLE, systemic lupus erythematosus; TGF-b,
transforming growth factor-b; HDAC, histone deacteylase; NO, nitric oxide; INS, insulinoma.
doi:10.1371/journal.pone.0009576.t003
Table 3. Cont.
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region. However to find these genes new approaches for analysing
genetic association data are needed.
In the current study we have developed a method which
combines genetic association data with information on functional
protein-protein interaction networks for the corresponding genes.
Using a stratification based on HLA-DRB1 risk alleles we have
identified functional protein interaction pathways that are able to
discriminate between carriers of the *0301 or the *0401 risk
alleles. One advantage of this approach is that it might make it
possible to circumvent the issue with LD between genes as most
interactions between proteins are not likely to depend on LD.
However, we need to acknowledge that the extended LD between
genes on chromosome 6p21 and the function of the genes within
the same protein complexes make it difficult to account for LD in
Table 4. Genes in consensus networks of the DR3/DR4, DR4/DR4 and DR4/DRX groups.
DR3/DR4
DR4/DR4
DR4/DRX
Gene Full name Chromosome GO terms Description
Consensus
network 1
PSMB8 and
PSMB9
Proteasome subunit, beta
type, 8 and 29
6p21.3 1) anaphase-promoting complex-dependent
proteasomal ubiquitin-dependent protein
catabolic process 2) negative regulation of
ubiquitin-protein ligase activity during mitotic
cell cycle 3) positive regulation of ubiquitin-
protein ligase activity during mitotic cell cycle
4) protein binding
Involved in processing and assembling of
endogenous peptides with MHC class I molecules,
presented on the surface of antigen presenting cells
where the antigens are recognised by CD8+ T-cells.
PSMB8 and PSMB9 are subunits of the proteasome
which is responsible for the degradation and
cleavage of proteins and catalysis of antigen
processing [29].
TAP1 and TAP2 Transporter 1, ATP-binding
cassette sub-family B
(MDR/TAP) and 2
6p21.3 1) antigen processing and presentation of
exogenous protein antigen via MHC class I,
TAP-dependent 2) cytosol to ER transport 3)
intracellular protein transport 4) protein
complex assembly 5) ATP binding 6) homo-
aconitate hydratase activity 7) MHC class
I protein binding 8) peptide antigen binding
9) peptide antigen-transporting ATPase
activity 10) phosphate binding 11) protein
heterodimerization activity 12) tapasin
binding 13) transporter activity
Thereafter the peptides are transported from the
cytosol into the endoplasmic reticulum (ER) by TAP
molecules for assembly with MHC class I molecules.
TAP1 and TAP2 encode subunits of the TAP
heterodimer. Allelic variations within the PSMB and
TAP genes have been studied previously in T1D,
reviewed in [29].
ABCB5 ATP-binding cassette,
sub-family B (MDR/TAP),
member 5
17p15.3 1) transport A member of a super-family of integral membrane
proteins that participate in transport of various
molecules such as ions, sugars and peptides in an
ATP-dependent manner. Expressed in CD133-
expressing progenitor cells of human epidermal
melanocytes and was believed to be involved in cell
fusion [65]. Two isoforms of ABCB5 were studied for
their expression profiles in melanoma cell lines and
normal tissues. Both isoforms were expressed in most
types of melanomas, melanocytes and retinal
epithelial cells but was not detected in other tissues,
such as liver, spleen, thymus, colon or peripheral
blood leukocytes, suggesting a pigment cell-specific
expression [66].
Consensus
network 2
HLA-DQB1 and
HLA-DQA1
Major histocompatibillity
complex, class II, DQ
beta 1 and 2DQ alpha 1
6p21.3 1) immune response 2) MHC class II receptor
activity
The genetic risk of T1D conferred by alleles of HLA-
DQB1 and HLA-DQA1 has been well studied [3]. The
highest risk is conferred by alleles in the class II genes
HLA-DQB1, -DQA1 and -DRB1.
HCRT Hypocretin (orexin)
neuropeptide precursor
17q21 1) synaptic transmission Hypocertin is associated with narcolepsy, a chronic
disabling sleep disorder of unknown origin. The allele
HLA-DQB1*0602 is associated with susceptibility to
narcolepsy [67], but is known to cause dominant
protection from T1D. The crystal structure of purified
DQ*0602-hypocretin molecules was studied to
elucidate the functional mechanisms for their
different effects. Different characteristics of peptide-
binding pockets where highlighted as important for
the effects of this allele on the two diseases [68]. HLA-
DQB1*0602 is also strongly associated with
susceptibility to multiple sclerosis [69].
GO terms on biological process and molecular function from www.geneontology.org.
Abbreviations: ATP, adenosine triphosphate.
doi:10.1371/journal.pone.0009576.t004
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our analysis. Furthermore, the association signals from SNPs
within genes within the HLA region are most likely confounded by
the strong LD with HLA-DRB1, DQA1 and DQB1 alleles. In the
developed approach we have evaluated the enrichment of T1D
associated HLA proteins within interaction networks. Firstly, in
the randomisation we compared the average association signal for
Figure 3. Consensus networks. A) displays the consensus network for the DR3/DR3 and the DR3/DRX risk groups. B) displays the consensus
network for the DR3/DR4 and the DR4/DRX risk group. C) displays the consensus network for the DR4/DR4 risk group. Proteins encoded from genes
in the HLA region are shown in red.
doi:10.1371/journal.pone.0009576.g003
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each network to the signal from randomly generated HLA proteins
networks that originated from the same TDT p-value distribution.
Secondly, we compared the p-value distribution within each HLA
risk group to the clustered distribution in the Kolmogorov-
Smirnov test. In Figure 2 we can see that the DR3/3 and DR3/
X groups are significantly more clustered than the reference.
However, also the most associated networks in each HLA risk
group have lower observed p-values than expected and are thus
more clustered than the reference, indicating that the networks
add information to the genetic association for the HLA risk
groups. The protein-protein interaction analyses performed in the
current study is in silico, however the identified interactions are
based on documented interaction data with references in the
literature, weighted towards physical interactions and should be
useful for guiding future biological experiments [22]. The protein-
protein interaction data used in this study contained only high-
confidence functional interactions, however many of the HLA
proteins identified are involved in a large number of interactions
with proteins outside the HLA region, as can be seen in Table 1.
In an effort to reduce the complexity of the interactions contained
in the network modules we constructed consensus networks based
on the most abundant HLA proteins for each risk group and only
included partners outside the HLA with a stringent criteria (see
Methods).
Using this novel approach we were able to highlight functional
interaction pathways for proteins that are encoded by the HLA
region on chromosome 6. The common pathways that were
identified for the carriers of the DRB1*0301 allele (summarised in
Table 3) pinpoint genes and proteins involved in stress response
and inflammation, such as the heat shock protein family and
pathways leading to NF-kB activated gene transcription. Several
of the genes that were identified as interaction partners outside the
HLA region, although having diverse functions such as kinases,
transcription factors and membrane transporters, are associated
with roles in inflammation and thus constitute candidates with a
role in the pathogenesis of autoimmunity.
In contrast the pathways identified in carriers of the DR*0401
allele (Table 4) highlighted proteins involved in antigen
processing and transport, such as PSMB8, PSMB9, TAP1 and
TAP2 as well as proteins involved in MHC class I and class II
presentation. The genes PSMB8 and PSMB9 are located next to
TAP1 and TAP2 in the class II region and encodes the inducible
catalytic components LMP7 and LMP2 of the immunoprotea-
some, a specialised proteasome complex expressed upon stimula-
tion with inflammatory cytokines. The proteasome is an enzymatic
complex involved in the catalytic degradation of proteins in
eukaryotic cells, including processing of antigenic peptides
presented on MHC class I molecules [29]. Another important
role for the proteasome is the activation of NF-kB, via processing
of the NF-kB precursor and degradation of the inhibitory protein
IkBa. Several studies investigating the function of the immuno-
proteasome in DR4-associated immune-mediated diseases have
found altered functions not only in antigen processing but also in
other aspects of the immune response [30–33].
Suggested environmental triggers of T1D have included viral
infections and exposure to exogenous proteins, such as bovine
insulin from cow’s milk. The antigen processing pathway
highlighted in the DR4-linked networks could provide indirect
evidence for the involvement of exogenous proteins in the
pathogenesis of immune-mediated diseases, as viral antigens are
known to be processed via the immunoproteasome and presented
on MHC class I molecules. Evidence for altered immunoprotea-
some expression and function following viral and parasite infection
has also been demonstrated [34–36]. Taken together, these aspects
of the immunoproteasome functions suggest a prominent role in
regulating the immune response and pathogenesis of HLA DR-
associated immune-mediated diseases.
In a previous publication [24], we proved the feasibility of using
an approach that combines genetic association data with protein
interaction networks using a subset of the data provided by the
T1DGC. Apart from the classical HLA loci there is limited overlap
with the network modules identified in the present study, although
CD4 was found in significant networks in both studies. The reason
for this lack of overlap may be the increase in statistical power
provided by the increase in trios analysed in the full dataset, as well
as the stratification and focus of this study on HLA risk groups. In
addition the present study focuses on the most significant network
modules identified, however some of the proteins identified in [24]
were found among less significant modules identified in the present
study (data not shown).
Our study emphasises the importance of systems biology
approaches to complement more classical statistical analyses of
the genetics of T1D and other complex diseases. Genes and
proteins do not exert their functions as independent entities but
are part of functional protein complexes and signalling pathways.
The method that we have developed gives us the opportunity to
place the genetic association into a functional context, which
might help us understand the underlying mechanisms and
complex interplay between multiple factors contributing to disease
pathogenesis. The method is not only applicable in T1D but could
also be applied to association data from other common complex
diseases.
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